Tricyclic compound, its thereof and pharmaceutical composition containing thereof
Described is a tricyclic compound of the general formula (I), where particular substituents have the meaning defined in claims, or pharmaceutically acceptable salt or solvate thereof, its use for the manufacture of a medicament for the treatment of cancer, stroke, neurodegenerative diseases, inflamm...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Slovak |
Published |
07.07.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described is a tricyclic compound of the general formula (I), where particular substituents have the meaning defined in claims, or pharmaceutically acceptable salt or solvate thereof, its use for the manufacture of a medicament for the treatment of cancer, stroke, neurodegenerative diseases, inflammatory condition and cardiovascular diseases. Described is also a pharmaceutical composition comprising said compound, poly (ADP-ribose) polymerases inhibitor.
Je opísaná tricyklická zlúčenina všeobecného vzorca (I), kde jednotlivé substituenty majú význam definovaný v nárokoch, alebo farmaceutický prijateľná soľ alebo solvát tejto zlúčeniny, jej použitie na výrobu liečiva na liečenie rakoviny, mŕtvice, neurodegeneratívnych chorôb, zápalových stavov a kardiovaskulárnych chorôb. Je opísaná aj farmaceutická kompozícia s obsahom tejto zlúčeniny, inhibítora poly(ADP-ribóza)polymeráz. |
---|---|
Bibliography: | Application Number: SK20010000966 |